Net Income for AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's current net income (TTM) is $10.22B USD. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
AZN
Currently viewingNet IncomeSwitch metric
TTM (last 4 quarters)
$10.22B
YoY change
+45.8%
5Y CAGR
+26.3%
Peak year (2025)
$10.26B
Cumulative net income
$124.54B
Net Income history chart for AstraZeneca (AZN) from 1990 to 2025
Net Income history table for AstraZeneca (AZN) from 1990 to 2025
| Fiscal year | Period ended | Reported | Net Income | YoY |
|---|---|---|---|---|
| 2025 | $10.26B | +45.8% | ||
| 2024 | $7.04B | +18.1% | ||
| 2023 | $5.96B | +81.1% | ||
| 2022 | $3.29B | +2835.7% | ||
| 2021 | $112.00M | -96.5% | ||
| 2020 | $3.20B | +139.4% | ||
| 2019 | $1.33B | -38.1% | ||
| 2018 | $2.15B | -28.2% | ||
| 2017 | $3.00B | -14.2% | ||
| 2016 | $3.50B | +23.9% | ||
| 2015 | $2.83B | +129.1% | ||
| 2014 | $1.23B | -51.8% | ||
| 2013 | $2.56B | -59.0% | ||
| 2012 | $6.24B | -37.1% | ||
| 2011 | $9.92B | +23.1% | ||
| 2010 | $8.05B | +7.1% | ||
| 2009 | $7.52B | +23.3% | ||
| 2008 | $6.10B | +9.0% | ||
| 2007 | $5.59B | -7.4% | ||
| 2006 | $6.04B | +28.4% | ||
| 2005 | $4.71B | +28.4% | ||
| 2004 | $3.66B | +20.7% | ||
| 2003 | $3.04B | +7.0% | ||
| 2002 | $2.84B | -31.7% | ||
| 2001 | $4.16B | +63.6% | ||
| 2000 | $2.54B | +122.4% | ||
| 1999 | $1.14B | -3.6% | ||
| 1998 | $1.19B | -1.8% | ||
| 1997 | $1.21B | +9.6% | ||
| 1996 | $1.10B | +112.1% | ||
| 1995 | $519.19M | -25.0% | ||
| 1994 | $692.59M | +8.6% | ||
| 1993 | $637.54M | +425.4% | ||
| 1992 | $121.34M | -81.2% | ||
| 1991 | $645.56M | +50.8% | ||
| 1990 | $428.22M | — |
Net Income values are taken from AstraZeneca's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
AstraZeneca (AZN) most recent annual net income stands at $10.26B (2025) – surged 45.8% year-over-year.
Looking at the 2020–2025 (5 years) stretch, AstraZeneca net income compounded at +26.3% per year, sustaining 4 straight years of year-over-year growth.
The dataset's maximum net income sits at $10.26B (2025); the minimum reading of $112.00M dates to 2021.
AstraZeneca (AZN) sits 6th of 8 Healthcare peers we track on this metric, against a peer median of $15.15B.
AstraZeneca Net Income by Year
AstraZeneca Net Income 2025: $10.26B
AstraZeneca net income in 2025 was $10.26B, surged 45.8% from 2024. This figure represents the highest annual value in the available history.
AstraZeneca Net Income 2024: $7.04B
AstraZeneca net income in 2024 was $7.04B, grew 18.1% from 2023.
AstraZeneca Net Income 2023: $5.96B
AstraZeneca net income in 2023 was $5.96B, surged 81.1% from 2022.
AstraZeneca Net Income 2022: $3.29B
AstraZeneca net income in 2022 was $3.29B, surged 2835.7% from 2021.
AstraZeneca Net Income 2021: $112.00M
AstraZeneca net income in 2021 was $112.00M.
See more financial history for AstraZeneca (AZN).
Sector peers — Net Income
Companies in the same sector as AstraZeneca, ranked by their latest net income.
| Company | Net Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $102.43B | Healthcare |
| Johnson & Johnson (JNJ) | $26.80B | Healthcare |
| Eli Lilly and Company (LLY) | $20.64B | Healthcare |
| Merck & Co., Inc. (MRK) | $18.25B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $12.06B | Healthcare |
| Amgen Inc. (AMGN) | $7.71B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $6.74B | Healthcare |
| AbbVie Inc. (ABBV) | $4.23B | Healthcare |
Frequently asked questions
What is AstraZeneca's net income?
- Latest reported net income for AstraZeneca (AZN) is $10.22B (period ending December 31, 2025).
How has AstraZeneca net income changed year-over-year?
- AstraZeneca (AZN) net income changed +45.8% year-over-year on the latest annual filing.
What is the long-term growth rate of AstraZeneca net income?
- AstraZeneca (AZN) net income compound annual growth rate is +26.3% over the most recent 5 years available.
When did AstraZeneca net income hit its highest annual value?
- AstraZeneca net income reached its highest annual value of $10.26B in 2025.
What was AstraZeneca net income in 2024?
- AstraZeneca (AZN) net income in 2024 was $7.04B.
What was AstraZeneca net income in 2025?
- AstraZeneca (AZN) net income in 2025 was $10.26B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
AZN Overview
Company profile, financial tools, and key metrics
AZN Revenue Counter
Earns $1,863 every second. See per minute, hour, and day.
AZN Earnings Counter
Earns $324.23 per second net profit. See per minute, hour, and day.
AZN Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
AZN What If Invested
What if you had invested $1,000? See historical returns from any date.
AZN How It Makes Money
Discover visual breakdown of $58.74B in revenue — where it comes from and where it goes.
AZN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AZN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AZN Daily Price Character
Steady · 49.4% historical win rate (green days). Streaks & record days.
AZN Buybacks
0.16% TTM buyback yield. Shareholder yield & SBC comparison.
AZN Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
AZN Dividend Profile
Yield: 1.73%. Safety: 6/8. See full history.
AZN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AZN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.